… -induced immune responses amongst the three vaccines using identical immunological assays
10,11,12 . In this study, we assessed a cohort of SARS-CoV-2 naive individuals … COV2.S …

… There were limitations inherent in this study: while new SARS-CoV-2 vaccine data is being
produced rapidly, we have had to impose a finite search window, excluding some candidates …

… We and others have previously shown that the ChAdOx1 nCoV-19 vaccine contains a
large … of a comprehensive, comparative analysis of the ChAdOx1 nCoV-19 and Ad26.COV2.S …

… .529) of SARS-CoV-2 has demonstrated partial vaccine escape and high transmissibility,
with early studies indicating lower severity of infection than that of the delta variant (B.1.617.2). …

… study was to describe self-reported vaccine adverse events after receiving one of the available
COVID-19 vaccine … This study aimed to describe the self-reported vaccine adverse events …

… study, both BNT162b2 and Gam-COVID-Vac vaccines demonstrated stronger initial peak
response in comparison … benefits of vaccination against SARS-CoV-2 as a preventive measure. …

… COVID-19 vaccines, in particular that of Moderna, for both humoral and cellular immunogenicity.
Our results comparing between different vaccine … further national vaccination programs. …

… study was to provide an up-to-date comparative analysis of the characteristics, adverse
events, efficacy, effectiveness and impact of the variants of concern for 19 COVID-19 vaccines. …

… This study aimed to compare the characteristics of fully and partially vaccinated or unvaccinated
coronavirus disease 2019 (COVID-19) patients who were hospitalised in a population of …

… In this study, we aimed to evaluate vaccine reactivity and disease … studies, vaccines that
use mRNA technology were found to be more effective in preventing symptomatic COVID-19 …